000 | 01901 a2200493 4500 | ||
---|---|---|---|
005 | 20250514232945.0 | ||
264 | 0 | _c20050823 | |
008 | 200508s 0 0 eng d | ||
022 | _a0161-5505 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKoch, Walter | |
245 | 0 | 0 |
_aClinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. _h[electronic resource] |
260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cJul 2005 |
||
300 |
_a1109-18 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
650 | 0 | 4 | _aDopamine Plasma Membrane Transport Proteins |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImage Interpretation, Computer-Assisted _xmethods |
650 | 0 | 4 |
_aImaging, Three-Dimensional _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
650 | 0 | 4 |
_aMembrane Transport Proteins _xmetabolism |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
650 | 0 | 4 | _aObserver Variation |
650 | 0 | 4 |
_aParkinson Disease _xdiagnostic imaging |
650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aSoftware |
650 | 0 | 4 | _aSubtraction Technique |
650 | 0 | 4 |
_aTomography, Emission-Computed, Single-Photon _xmethods |
650 | 0 | 4 |
_aTropanes _xpharmacokinetics |
700 | 1 | _aRadau, Perry E | |
700 | 1 | _aHamann, Christine | |
700 | 1 | _aTatsch, Klaus | |
773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 46 _gno. 7 _gp. 1109-18 |
|
999 |
_c15656826 _d15656826 |